3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
40
Glioma
17
Brain Neoplasms
14
Astrocytoma
11
Neuroblastoma
10
Gliosarcoma
10
Neoplasms
8
Sarcoma, Ewing
7
Rhabdomyosarcoma
6
Recurrence
5
Oligodendroglioma
5
Sarcoma
4
Medulloblastoma
4
Neoplasm Metastasis
3
Diffuse Intrinsic Pontine Glioma
3
Wilms Tumor
2
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Melanoma
2
Lymphoma, Follicular
2
Hepatoblastoma
2
Central Nervous System Neoplasms
2
Spinal Cord Neoplasms
1
Somatostatinoma
1
Rhabdoid Tumor
1
Refractory Solid Tumors
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Interventions
Cyclophosphamide
3
Gemcitabine
2
regorafenib
1
liposomal doxorubicin
1
lenvatinib
1
fludarabine
1
alectinib
1
aldesleukin
1
Weight-Bearing
1
Taxes
1
Surveys and Questionnaires
1
Restraint, Physical
1
Range of Motion, Articular
1
Quality of Life
1
Proton Therapy
1
Platinum
1
Paclitaxel
1
Nivolumab
1
Metastasectomy
1
Masks
1
Lomustine
1
Irinotecan
1
Ipilimumab
1
Everolimus
1
Etoposide
1
Doxorubicin
1
Data Collection
1
Cisplatin
1
Carboplatin
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
Temozolomide
×
90 days
×
Clear all
No trials found.